title: [Pharmacological profile and clinical findings of a new phosphate binder, ferric citrate hydrate (Riona® Tablets)].
authors.forename: Akira
authors.initials: A
authors.lastname: Miyazaki
authors.forename: Akira
authors.initials: A
authors.lastname: Matsuo
authors.forename: Akio
authors.initials: A
authors.lastname: Iida
authors.forename: Noriaki
authors.initials: N
authors.lastname: Nishino
authors.forename: Kazuo
authors.initials: K
authors.lastname: Maeda
authors.forename: Yu
authors.initials: Y
authors.lastname: Matsumoto
authors.forename: Satoshi
authors.initials: S
authors.lastname: Orui
mesh_terms: D000818:Animals; D002614:Chelating Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005290:Ferric Compounds / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D005293:Ferritins / Q000097:blood; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D054559:Hyperphosphatemia / Q000188:drug therapy* / Q000209:etiology; D010530:Peritoneal Dialysis; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000150:complications; D013607:Tablets
chemical_list: D002614:Chelating Agents; D005290:Ferric Compounds; D013607:Tablets; C025314:ferric citrate; D005293:Ferritins